Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV)
- PMID: 9021050
- DOI: 10.1016/s0166-3542(96)01004-2
Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV)
Abstract
Prostratin, a non-tumor-promoting phorbol ester, inhibited human immunodeficiency virus (HIV)-induced cell killing and viral replication in a variety of acutely-infected cell systems. The potency and degree of cytoprotection was dependent on both viral strain and host cell type. Prostratin activated viral expression in two latently-infected cell lines, but had little or no effect on chronically-infected cell lines. Prostratin caused a dose-dependent, but reversible, decrease in CD4 expression in the CEM-SS and MT-2 cell lines. This down-regulation of CD4 was inhibited in a dose-dependent manner by the protein kinase C (PKC) antagonist, staurosporine. In addition, the cytoprotective and cytostatic effects of prostratin in CEM-SS cells acutely infected with HIV-1RF were reversed by bryostatin-1, a PKC agonist. Prostratin had no effect on reverse transcriptase or HIV-1 protease, nor did it inhibit the binding of gp120 to CD4. We conclude that prostratin inhibits HIV cytopathicity and replication through mechanism(s) involving PKC enzyme(s).
Similar articles
-
A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1.J Med Chem. 1992 May 29;35(11):1978-86. doi: 10.1021/jm00089a006. J Med Chem. 1992. PMID: 1597853
-
Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.J Virol. 2004 Oct;78(19):10507-15. doi: 10.1128/JVI.78.19.10507-10515.2004. J Virol. 2004. PMID: 15367617 Free PMC article.
-
4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.Biochem Pharmacol. 2020 Jul;177:113937. doi: 10.1016/j.bcp.2020.113937. Epub 2020 Mar 26. Biochem Pharmacol. 2020. PMID: 32224142
-
Prostratin: An Overview.Mini Rev Med Chem. 2015;15(13):1122-30. doi: 10.2174/1389557515666150511154108. Mini Rev Med Chem. 2015. PMID: 25963564 Review.
-
Prostratin as a new therapeutic agent targeting HIV viral reservoirs.Drug News Perspect. 2005 Oct;18(8):496-500. doi: 10.1358/dnp.2005.18.8.944543. Drug News Perspect. 2005. PMID: 16391719 Review.
Cited by
-
The Role of Plant Latex in Virus Biology.Viruses. 2023 Dec 27;16(1):47. doi: 10.3390/v16010047. Viruses. 2023. PMID: 38257746 Free PMC article. Review.
-
Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs.Adv Virol. 2012;2012:805347. doi: 10.1155/2012/805347. Epub 2012 Mar 5. Adv Virol. 2012. PMID: 22500169 Free PMC article.
-
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.PLoS Pathog. 2015 Jul 30;11(7):e1005063. doi: 10.1371/journal.ppat.1005063. eCollection 2015 Jul. PLoS Pathog. 2015. PMID: 26225566 Free PMC article.
-
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.PLoS Pathog. 2013;9(12):e1003834. doi: 10.1371/journal.ppat.1003834. Epub 2013 Dec 26. PLoS Pathog. 2013. PMID: 24385908 Free PMC article.
-
Identification of small-molecule ion channel modulators in C. elegans channelopathy models.Nat Commun. 2018 Sep 26;9(1):3941. doi: 10.1038/s41467-018-06514-5. Nat Commun. 2018. PMID: 30258187 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials